VIZIDH Trademark

Trademark Overview


On Thursday, August 18, 2016, a trademark application was filed for VIZIDH with the United States Patent and Trademark Office. The USPTO has given the VIZIDH trademark a serial number of 87143137. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, January 26, 2024. This trademark is owned by Celgene Corporation. The VIZIDH trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in the treatment of beta thalassemia and myelodysplastic syndromes, autoinflammatory disease, autoimmune disease, blood disease, cancer, arthritis, musculoskeletal and skin diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system
vizidh

General Information


Serial Number87143137
Word MarkVIZIDH
Filing DateThursday, August 18, 2016
Status710 - CANCELLED - SECTION 8
Status DateFriday, January 26, 2024
Registration Number5239908
Registration DateTuesday, July 11, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 7, 2017

Trademark Statements


Goods and ServicesPharmaceutical preparations for use in the treatment of beta thalassemia and myelodysplastic syndromes, autoinflammatory disease, autoimmune disease, blood disease, cancer, arthritis, musculoskeletal and skin diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, January 26, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCelgene Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Party NameCelgene Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Trademark Events


Event DateEvent Description
Friday, January 26, 2024CANCELLED SEC. 8 (6-YR)
Monday, July 11, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, July 11, 2017REGISTERED-PRINCIPAL REGISTER
Friday, June 2, 20171(B) BASIS DELETED; PROCEED TO REGISTRATION
Tuesday, May 2, 2017NOTICE OF ALLOWANCE CANCELLED
Friday, May 19, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 2, 2017TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, May 2, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 7, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 7, 2017PUBLISHED FOR OPPOSITION
Wednesday, February 15, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, February 2, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, January 18, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 6, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 6, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 15, 2016ASSIGNED TO LIE
Thursday, December 1, 2016TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, November 21, 2016NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, November 21, 2016LETTER OF SUSPENSION E-MAILED
Monday, November 21, 2016SUSPENSION LETTER WRITTEN
Wednesday, November 16, 2016ASSIGNED TO EXAMINER
Tuesday, August 23, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 22, 2016NEW APPLICATION ENTERED